Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non Severe Ischemic Stroke”

12 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 12 of 12 results

Large-scale testing (Phase 3)Active Not RecruitingNCT05739383
What this trial is testing

Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.

Who this might be right for
Primary Prevention of Atherosclerotic Cardiovascular Disease
Novartis Pharmaceuticals 14,012
Not applicableNot Yet RecruitingNCT07112547
What this trial is testing

Occurrence of Severe Cardiac Rhythm and Conduction Disturbances in Emergency Department Patients With Non-ST Elevation Acute Coronary Syndrome

Who this might be right for
Acute Coronary Syndrome Without ST Elevation on ElectrocardiogramAcute Coronary Syndromes (ACS)Myocardial Infarction, Unstable Angina Pectoris, Sudden Cardiac Death, Stroke, Peripheral Artery Disease
University Hospital, Strasbourg, France 500
Testing effectiveness (Phase 2)Study completedNCT04063215
What this trial is testing

A Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Autologous Mesenchymal Stem Cell Therapy for the Treatment of Traumatic Brain Injury and Hypoxic-Ischemic Encephalopathy

Who this might be right for
Traumatic Brain Injury
Hope Biosciences LLC 24
Not applicableStudy completedNCT03568916
What this trial is testing

Direct Oral Anticoagulants in Patients With Atrial Fibrillation (DOACs vs DOACs)

Who this might be right for
Atrial FibrillationIschemic StrokeSystemic Embolization+3 more
Canadian Network for Observational Drug Effect Studies, CNODES 227,579
Not applicableStudy completedNCT03596502
What this trial is testing

Direct Oral Anticoagulants in Patients With Atrial Fibrillation (DOACs vs Warfarin)

Who this might be right for
Atrial FibrillationIschemic StrokeSystemic Embolization+3 more
Canadian Network for Observational Drug Effect Studies, CNODES 402,764
Not applicableStudy completedNCT07345078
What this trial is testing

Study on the Treatment of Post-stroke Dysphagia and Stroke-associated Pneumonia With Bronchoscopy

Who this might be right for
Stroke Associated PneumoniaNon Severe Ischemic StrokeDysphagia
The First People's Hospital of Zunyi 50
Not applicableStudy completedNCT03222024
What this trial is testing

Cohort Study for Severe Ischaemic Stroke

Who this might be right for
Severe Ischaemic StrokeMalignant Ischaemic Stroke
West China Hospital 2,500
Post-approval studies (Phase 4)Study completedNCT00327418
What this trial is testing

CARDS Is Designed To Show If Lowering Cholesterol With Atorvastatin In Type 2 Diabetics Without CV Disease Reduces The Risk Of CV Events

Who this might be right for
Major Coronary EventCerebrovascular AccidentCoronary Artery Bypass Graft+2 more
Pfizer 2,800
Not applicableStudy completedNCT05974345
What this trial is testing

In Silico Study Assessing the Impact of Inclisiran on Major Adverse Cardiovascular Events in Patients With Established Cardiovascular Disease

Who this might be right for
Atherosclerotic Cardiovascular Disease
Novartis Pharmaceuticals 204,691
Testing effectiveness (Phase 2)Ended earlyNCT04416048
What this trial is testing

Effect of Anticoagulation Therapy on Clinical Outcomes in COVID-19

Who this might be right for
COVID-19
Charite University, Berlin, Germany 111
Not applicableLooking for participantsNCT06951867
What this trial is testing

Tezspire Cardiac Events PASS

Who this might be right for
Cardiovascular EventsMACE
AstraZeneca 16,640
Post-approval studies (Phase 4)UnknownNCT05559307
What this trial is testing

Analyzing the Pharmacodynamic Substances and the Effects of Xingnaojing for Mild-to-Severe Acute Ischemic Stroke

Who this might be right for
Ischemic Stroke, Acute
Ying Gao 20